Replies to post #29240 on OncoSec Medical Inc (ONCSQ)

[lasers]

mybikeisorange read the $OCAT PR as posted by PD and reference the areas of your points that you are trying to make.

http://ir.stockpr.com/oncosec/company-news/detail/1634/uc-san-francisco-and-oncosec-medical-collaborate-to-evaluate-investigational-combination-of-immunopulse-and-anti-pd-1-treatment

[JackyLy]

I'm not rewriting anything.

This Phase II clinical trial will be conducted as a multicenter Investigator Sponsored Trial (IST), with UCSF and Dr. Alain Algazi as the sponsor. Merck will supply pembrolizumab, and OncoSec will provide electroporation devices and plasmid IL-12. Enrollment is expected to begin in Q1 2015.

Simply defining what a multicenter investigator sponsored trial means will tell you all 3 are in a collaboration.